Intuitive Surgical sees slower 2017 procedure growth, buys back shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow on course for slim gains at open as Iran tensions clash with AI optimism
- Oil retreats from one-month high as traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Canaccord Genuity Reiterates Buy on Intuitive Surgical (ISRG) Following 4Q Report
January 25, 2017 9:35 AM ESTCanaccord Genuity reiterated a Buy rating and $800.00 price target on Intuitive Surgical (NASDAQ: ISRG) following the company's 4Q earnings report. Management reiterated expectations for 2017 procedure growth in the range of 9-12%. The company also issued first-time pro forma GM guidance, projecting gross margins in the range of 69-71%.
Analyst Jason Mills commented, "ISRG is shaping up to be one of the most compelling large-cap med-tech stocks in the sector, in our view; thus, we stay buyers of the stock. Coming... More
